Last Updated on October 6, 2024 by The Health Master
New Delhi: Incyte Corp said its monoclonal antibody, Zynyz, has won accelerated approval from the U.S. health regulator for treating a rare and aggressive type of skin cancer in adults. The U.S. Food and Drug Administration (USFDA) approved the therapy in Merkel cell carcinoma (MCC) patients for whom the cancer has come back or spread to other parts of the body.
The company expects Zynyz to be available to eligible patients by early April. The company also said that MCC impacts less than 1 per 100,000 people in the U.S. but incidence rates are rising.
Zynyz belongs to a class of drugs known as PD-1 inhibitors that help the immune system to attack cancer by blocking a mechanism tumors use to evade detection. Incyte said the monthly price of treatment with Zynyz will be comparable with other drugs in the same class that are currently available.
Drugs such as Merck & Co Inc’s blockbuster Keytruda and Merck KGaA and Pfizer Inc’s Bavencio are approved to treat MCC.
The list price for each dose of Keytruda when it is given every three weeks is $10,683.52, according to its website.
Keytruda is “heavily entrenched” in the indication, brokerage William Blair said, adding that it sees limited commercial opportunity for Zynyz.
The therapy was developed by MacroGenics Inc and licensed to Incyte in 2017.
MacroGenics shares were down nearly 5%, while Incyte was down about 1%.
The approval for Zynyz was based on a mid-stage study, which showed the therapy helped decrease the size of tumors or remove all signs of the cancer in patients.
An accelerated approval means companies will still be required to conduct studies to confirm the anticipated clinical benefit.
USFDA gives approval for Calcipotriene and Betamethasone foam
USFDA gives approval for Brexpiprazole tablets
USFDA gives approval for generic Rocuronium Bromide Injection
USFDA gives approval for Prochlorperazine Maleate Tablets USP
USFDA gives approval for Ranolazine ER tablets
USFDA gives nod for Human Trial of drug for the treatment of advanced cancer
USFDA issues Form 483 with 2 observations to Alembic, Gujarat
USFDA gives approval for Calcipotriene and Betamethasone foam
West Bengal notice to Pharma Industry on bio-resource use
USFDA gives approval for Brexpiprazole tablets
Govt constitutes panel for PLI scheme for pharmaceuticals
USFDA gives approval for generic Rocuronium Bromide Injection
Difference: Disintegration and Dissolution test in pharma industry
How to prepare SOPs in the Pharma Industry
Difference between branded and generic medicines
Understanding DQ, IQ, PQ, and OQ in the Pharma Industry
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
